As of 2025-07-11, the EV/EBITDA ratio of Sutro Biopharma Inc (STRO) is 0.15. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. STRO's latest enterprise value is -37.16 mil USD. STRO's TTM EBITDA according to its financial statements is -255.21 mil USD. Dividing these 2 quantities gives us the above STRO EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.2x - 13.8x | 13.1x |
| Forward P/E multiples | 16.7x - 31.2x | 20.8x |
| Fair Price | (49.26) - (40.50) | (49.96) |
| Upside | -6123.9% - -5052.4% | -6208.9% |
| Date | EV/EBITDA |
| 2025-07-09 | 0.16 |
| 2025-07-08 | 0.16 |
| 2025-07-07 | 0.17 |
| 2025-07-03 | 0.16 |
| 2025-07-02 | 0.16 |
| 2025-07-01 | 0.19 |
| 2025-06-30 | 0.18 |
| 2025-06-27 | 0.17 |
| 2025-06-26 | 0.15 |
| 2025-06-25 | 0.15 |
| 2025-06-24 | 0.14 |
| 2025-06-23 | 0.15 |
| 2025-06-20 | 0.15 |
| 2025-06-18 | 0.15 |
| 2025-06-17 | 0.15 |
| 2025-06-16 | 0.12 |
| 2025-06-13 | 0.15 |
| 2025-06-12 | 0.15 |
| 2025-06-11 | 0.14 |
| 2025-06-10 | 0.14 |
| 2025-06-09 | 0.14 |
| 2025-06-06 | 0.14 |
| 2025-06-05 | 0.14 |
| 2025-06-04 | 0.12 |
| 2025-06-03 | 0.11 |
| 2025-06-02 | 0.12 |
| 2025-05-30 | 0.12 |
| 2025-05-29 | 0.12 |
| 2025-05-28 | 0.11 |
| 2025-05-27 | 0.10 |
| 2025-05-23 | 0.11 |
| 2025-05-22 | 0.12 |
| 2025-05-21 | 0.14 |
| 2025-05-20 | 0.12 |
| 2025-05-19 | 0.13 |
| 2025-05-16 | 0.11 |
| 2025-05-15 | 0.13 |
| 2025-05-14 | 0.17 |
| 2025-05-13 | 0.15 |
| 2025-05-12 | 0.13 |
| 2025-05-09 | 0.13 |
| 2025-05-08 | 0.10 |
| 2025-05-07 | 0.09 |
| 2025-05-06 | 0.10 |
| 2025-05-05 | 0.07 |
| 2025-05-02 | 0.05 |
| 2025-05-01 | 0.06 |
| 2025-04-30 | 0.07 |
| 2025-04-29 | 0.13 |
| 2025-04-28 | 0.12 |